Stay updated on CIMAvax, Nivolumab & Pembrolizumab in Advanced Cancer Clinical Trial

Sign up to get notified when there's something new on the CIMAvax, Nivolumab & Pembrolizumab in Advanced Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CIMAvax, Nivolumab & Pembrolizumab in Advanced Cancer Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    The website has been updated from version 2.11.0 to 2.11.2, indicating new features or improvements.
    Difference
    0.0%
    Check dated 2024-10-03T04:58:03.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The website has been updated to Revision v2.11.0, while the previous version v2.10.5 has been removed, along with a notice regarding delays in study record information.
    Difference
    0.5%
    Check dated 2024-09-25T22:38:00.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    ClinicalTrials.gov is addressing delays in displaying study record information, and the website has been updated to version 2.10.5, replacing the previous version 2.10.3.
    Difference
    0.5%
    Check dated 2024-09-18T16:47:21.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    The website has been updated from version 2.10.2 to 2.10.3.
    Difference
    0.0%
    Check dated 2024-09-04T05:13:10.000Z thumbnail image
  7. Check
    51 days ago
    Change Detected
    Summary
    Recent updates clarify eligibility criteria for clinical trial participants, specifying that Phase I patients must have evaluable disease, while Phase II patients must have measurable disease as per RECIST 1.1, and outline restrictions on autoimmune disease treatments.
    Difference
    2%
    Check dated 2024-08-28T02:41:51.000Z thumbnail image
  8. Check
    65 days ago
    Change Detected
    Summary
    The website has been updated from version 2.10.0 to 2.10.2, indicating new features or improvements.
    Difference
    0.0%
    Check dated 2024-08-13T23:33:41.000Z thumbnail image

Stay in the know with updates to CIMAvax, Nivolumab & Pembrolizumab in Advanced Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CIMAvax, Nivolumab & Pembrolizumab in Advanced Cancer Clinical Trial page.